|By PR Newswire||
|February 25, 2014 08:01 AM EST||
CHICAGO, Feb. 25, 2014 /PRNewswire/ -- Allscripts (NASDAQ: MDRX) client Northeast Georgia Physicians Group (NGPG) has achieved the prestigious Stage 7, the highest level attainable, on the HIMSS Analytics Ambulatory Electronic Medical Record (EMR) Adoption ModelSM (A-EMRAM).
NGPG, a part of Northeast Georgia Health System located in Gainesville, Ga., is a multispecialty physicians group with more than 200 providers. Northeast Georgia Health System serves almost 800,000 people annually in more than 13 counties across Northeast Georgia. One of its hospitals, Northeast Georgia Medical Center was named one of America's 50 Best Hospitals in 2013 by Healthgrades® and is among only 20 large community hospitals named to Truven Health Analytics' list of the nation's 100 Top Hospitals.
NGPG utilizes Allscripts TouchWorks electronic health record. Allscripts TouchWorks EHR is a powerful multi-specialty ambulatory solution that offers automated clinical decision support at the point of care, a configurable clinical desktop, and nearly 800 peer-reviewed Care Guides, and is designed to help complex organizations manage their clinical, financial and operational needs.
"Northeast Georgia Health System is dedicated to leveraging its information technology systems to improve outcomes for the patients we serve," said Deven Mattheus, Chief Information Officer of NGPG. "Allscripts TouchWorks EHR is a reliable and robust solution that has been central to our efforts now validated and recognized with this HIMSS Analytics Stage 7 Award."
HIMSS Analytics EMR Adoption ModelSM is a methodology that measures the progress and impact of electronic health record (EHR) systems for organizations in the HIMSS Analytics® Database. According to HIMSS Analytics, there are eight stages (0-7) that measure a hospital's implementation and utilization of information technology applications. The final stage, Stage 7, represents an advanced patient record environment. The validation process to confirm a group has reached Stage 7 includes a site visit by an executive from HIMSS Analytics and former or current chief information officers to ensure an unbiased evaluation of the Stage 7 environments.
"Helping our clients reach their operational, financial and care goals is a priority for Allscripts," said Paul M. Black, President and Chief Executive Officer, Allscripts. "We wish to congratulate NGPG on reaching HIMSS Analytics Stage 7, an exceptional achievement that is a reflection of the commitment, dedication and hard work of NGPG's tremendous people."
Allscripts (NASDAQ: MDRX) delivers the insights that healthcare providers require to generate world-class outcomes. The company's Electronic Health Record, practice management and other clinical, revenue cycle, connectivity and information solutions create a Connected Community of Health™ for physicians, hospitals and post-acute organizations. To learn more about Allscripts, please visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2014 Allscripts Healthcare, LLC. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts. Other company and product names featured herein may be the trademarks of their respective owners.
This press release contains forward-looking statements within the meaning of the federal securities laws. Statements regarding future events or developments, our future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements with the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on our results of operations or financial condition. Such risks, uncertainties and other factors include, among other things: the possibility that our current initiatives focused on product delivery, client experience, streamlining our cost structure, and financial performance may not be successful, which could result in declining demand for our products and services, including attrition among our existing customer base; the impact of the realignment of our sales and services organization; potential difficulties or delays in achieving platform and product integration and the connection and movement of data among hospitals, physicians, patients and others; the risks that we will not achieve the strategic benefits of the merger with Eclipsys Corporation (Eclipsys) or our acquisition of dbMotion, Ltd. (dbMotion), or that the Allscripts products will not be integrated successfully with the Eclipsys and dbMotion products; competition within the industries in which we operate, including the risk that existing clients will switch to products of competitors; failure to maintain interoperability certification pursuant to the Health Information Technology for Economic and Clinical Health Act (HITECH), with resulting increases in development and other costs for us and possibly putting us at a competitive disadvantage in the marketplace; the volume and timing of systems sales and installations, the length of sales cycles and the installation process and the possibility that our products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; any costs or customer losses we may incur relating to the standardization of our small office electronic health record and practice management systems that could adversely affect our results of operations; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; errors or similar problems in our software products or other product quality issues; the outcome of any legal proceeding that has been or may be instituted against us and others; compliance obligations under new and existing laws, regulations and industry initiatives, including new regulations relating to HIPAA/HITECH, increasing enforcement activity in respect of anti-bribery, fraud and abuse, privacy, and similar laws, and future changes in laws or regulations in the healthcare industry, including possible regulation of our software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; the continued implementation and ongoing acceptance of the electronic record provisions of the American Recovery and Reinvestment Act of 2009, as well as elements of the Patient Protection and Affordable Care Act (aka health reform) which pertain to healthcare IT adoption, including uncertainty related to changes in reimbursement methodology and the shift to pay-for-outcomes; maintaining our intellectual property rights and litigation involving intellectual property rights; legislative, regulatory and economic developments; risks related to third-party suppliers and our ability to obtain, use or successfully integrate third-party licensed technology; breach of data security by third parties and unauthorized access to patient health information by third parties resulting in enforcement actions, fines and other litigation. See our Annual Report on Form 10-K/10K-A for 2012 and other public filings with the SEC for a further discussion of these and other risks and uncertainties applicable to our business. The statements herein speak only as of their date and we undertake no duty to update any forward-looking statement whether as a result of new information, future events or changes in expectations.
SOURCE Allscripts Healthcare Solutions, Inc.